Psychoactive properties of alpha-methyltryptamine: Analysis from self reports of users

Journal of Psychoactive Drugs

Volumn 44, Issue 3, 2012, Pages 274-276

  Wilcox, James ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Alpha methyltryptamine; Depression; Hallucinogen; Serotonin

Indexed keywords

ALPHA METHYLTRYPTAMINE; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DYSPHORIA; EMOTION; EUPHORIA; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; VISUAL HALLUCINATION;

ADOLESCENT; ADULT; ANXIETY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SELF REPORT; TRYPTAMINES; YOUNG ADULT;

EID: 84868125047     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2012.704592     Document Type: Article

References (19)

1. Boland, D.; Andollo, W.; Hime, G. & Hearn, W. 2005. Fatality due to alpha-methyltryptamine intoxication. Journal of Analytic Toxicology 29 (5): 394-97.
2. Brodey, J.; Steiner, W. & Himwich, H. 1963. An electrographic study of psilocin and 4-methyl-alpha-methyltryptamine. Journal of Pharmacology & Experimental Therapeutics 140: 8-18.
3. Federal Register. 2004. Schedules of controlled substances: Placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltrypamine into Schedule I of the Controlled Substances Act. Final Rule. 69 (188): 58950-3.
4. Gatch, M.; Forester, M.; Janowsky, A. & Eshleman, A. 2011. Abuse liability profile of three substituted tryptamine. Journal of Pharmacology & Experimental Therapeutics 338 (1): 280-89.
5. Glennon, R.; Chaurasia, C. & Titeler, M. 1990. Binding of indolylalkylamines at 5-HT2 serotonin receptors: Examination of a hydrophobic binding region. Journal of Medicinal Chemistry 33 (10): 2777-84.
6. Glennon, R.; Young, R.; Jacyno, J.; Slusher, M. & Rosecrans, J. 1983. DOM-stimulus generalization to LSD and other indolealkylamine. European Journal of Pharmacology 86 (3-4): 453-59.
7. Himwich, H. 1961. Experiments with alpha-methyltryptamine. Journal of Neuropsychiatry 2 (supplement): 136-40.
8. Hollister, L.; Prusmack, J.; Paulsen, A. & Rosenquist, N. 1960. Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects. Journal of Nervous & Mental Disease 131: 428-34.
9. Itokawa, M.; Iwata, K.; Takahashi, M.; Sugihara, G.; Sasaki, T.; Abe, Y.; Uno, M.; Hobo, M.; Jitoku, D.; Arai, M.; Yasuda, I. & Shintani, M. 2007. Acute confusional state after designer tryptamine use. Psychiatry & Clinical Neurosciences 61 (2): 196-99.
10. Long, H.; Nelson, L. & Hoffman, R. 2003. Alpha-methyltryptamine revisited via easy internet access. Veterinary & Human Toxicology 45 (3):149.
11. Lyon, R.; Titeler, M.; Seggel, M. & Glennon, R. 1988. Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens. European Journal of Pharmacology 145 (3): 291-97.
12. Merck & Co. 2006. Merck Index, 14th Edition. Whitehouse Station, NJ: Merck & Co.
13. Murphree, H.; Dippy, R.; Jenney, E. & Pfeiffer, C. 1961. Effects in normal man of alpha-methyltryptamine and alpha-ethyltryptamine. Clinical Pharmacology & Therapeutics 2: 722-26.
14. Rosner, B. 1982. Fundamentals of Biostatistics. Boston: PWS Duxbury Press.
15. Snyder, H. & Katz, L. 1947. The preparation ofmethyltryptamine. Journal of the American Chemical Society 69: 31-40.
16. Tedeschi, D.; Tedeschi, D.R.; Fowler, P.; Green, H. & Fellows, E. 1962. N-Methyl-alpha-methyl-tryptamine: A potent monoamine oxidase inhibitor and tryptamine antagonist. Biochemical Pharmacology 11: 481-85.
17. Terzian, A.; Safrasbekian, R.; Sukasian, R. & Tatevosian, G. 1961. Synthesis and some pharmacological properties of alphamethyltryptamine and its 5-methoxy derivative. Experientia 17: 493-94.
18. Vane, J.; Collier, H.; Corne, S.; Marely, E. & Bradley, P. 1961. Tryptamine receptors in the central nervous system. Nature 19: 1068-69.
19. Yeghiayn, S.; Kelly, A.; Kula, N.; Campbell, A. & Baldessarini, R. 1997. Role of dopamine in behavioral effects of serotonin microinjected into rat striatum. Pharmacology, Biochemistry & Behavior 56 (2): 251-59.